| Mrs Kari Miller, LMFT | |
|
118 W Jackson Ave, Iola, KS 66749 | |
| (620) 228-1181 | |
| Not Available |
| Full Name | Mrs Kari Miller |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 118 W Jackson Ave, Iola, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679940340 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | T-LMFT 2692 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kari Miller, LMFT 918 E Carpenter St, Iola, KS 66749-2105 Ph: () - | Mrs Kari Miller, LMFT 118 W Jackson Ave, Iola, KS 66749 Ph: (620) 228-1181 |
News Archive
"Cell division is one of the most fundamental aspects of biology, the process that makes life," says Iain Cheeseman, PhD. "And it has an intrinsic beauty."
Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck's investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S. Food and Drug Administration.
At Weight Watchers, we're proud that US News & World Report and the 22 independent experts who participated in the second annual Best Diets rankings have recognized us as the #1 program again for "Best Weight-Loss Diet" and "Best Commercial Diet Plan". We are also thrilled to have earned the top ranking in the new "Easiest Diet to Follow" category.
Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery.
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
› Verified 7 days ago
Jessica Eltomi, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 304 N Jefferson Ave, Iola, KS 66749 Phone: 620-365-5717 |